As meningiomas across all WHO grades express high levels of somatostatin receptor 2 (SSTR2), DOTATATE PET/CT and PET/MRI have emerged as a valuable adjunct modality in meningioma staging and management [[4], [5], [6], [7], [8]]. Here, SSTR2 is linked to meningioma.